REVIEW
Accepted on 23 May 2025
High-Risk Neuroblastoma in Mexico: From Multimodal Treatment to Immunotherapy. Regarding the first case treated with Naxitamab
doi 10.3389/fonc.2025.1520171
1,074
Total downloads
4,713
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
REVIEW
Accepted on 23 May 2025
ORIGINAL RESEARCH
Published on 15 Apr 2025
ORIGINAL RESEARCH
Published on 05 Mar 2025
CLINICAL TRIAL
Published on 03 Oct 2024
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: